Lothar Sobeck

Title: Lothar Sobeck: Innovator in Pharmaceutical Chemistry

Introduction

Lothar Sobeck is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on 11-benzaldoxime-estra-diene derivatives. With a total of 2 patents to his name, Sobeck's inventions demonstrate a commitment to advancing medical science.

Latest Patents

Sobeck's latest patents include the development of new 11-benzaldoxime-estra-diene derivatives, which are characterized by their strong antigestagenic effects combined with reduced glucocorticoid activity. The first patent details a method for producing these compounds and their pharmaceutically acceptable salts. The second patent focuses on a specific derivative, 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethyl-estrasdiene, which is produced through esterification or etherification of a related compound. Both inventions hold promise for the pharmaceutical industry.

Career Highlights

Lothar Sobeck is associated with Jenapharm GmbH, a company known for its focus on pharmaceutical development. His work has contributed to the company's reputation for innovation in the field. Sobeck's research has led to advancements that may improve therapeutic options for patients.

Collaborations

Sobeck has collaborated with notable colleagues such as Gerd Schubert and Michael Oettel. These partnerships have likely enhanced the scope and impact of his research efforts.

Conclusion

Lothar Sobeck's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic compounds.